Aerovate Therapeutics shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Aerovate Therapeutics (AVTE) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Aerovate Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aerovate Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aerovate Therapeutics by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $118k | 5.2k | 22.63 |
| 2023-09-30 | $71k | 5.2k | 13.57 |
| 2023-06-30 | $90k | 5.2k | 17.15 |
| 2023-03-31 | $105k | 5.2k | 20.17 |
| 2022-12-31 | $153k | 5.2k | 29.30 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors